Standard Biotools Inc (LAB) — Financial Flexibility Index
Standard Biotools Inc (LAB) has a Financial Flexibility Index of -0.59x as of March 2026. Free cash flow of $-46.03 Million (operating CF $-46.60 Million minus capex $570.00K) represents -1% of total liabilities ($77.99 Million). Check Standard Biotools Inc strategic capital allocation to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Standard Biotools Inc Financial Flexibility Index (2006–2025)
Historical Financial Flexibility Index trend for Standard Biotools Inc across 20 annual periods. See Standard Biotools Inc current assets vs equity to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Standard Biotools Inc (2006–2025)
Year-by-year free cash flow to debt coverage for Standard Biotools Inc. For the full company profile including market capitalisation, see LAB stock market capitalisation.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.46x | $-66.05 Million | $-74.35 Million | $143.46 Million | ▲ +52.1% |
| 2024 | -0.96x | $-135.10 Million | $-143.45 Million | $140.62 Million | ▼ -1018.8% |
| 2023 | -0.09x | $-40.46 Million | $-43.29 Million | $471.12 Million | ▲ +52.6% |
| 2022 | -0.18x | $-85.55 Million | $-89.37 Million | $471.78 Million | ▼ -6.3% |
| 2021 | -0.17x | $-30.80 Million | $-44.06 Million | $180.62 Million | ▼ -1072.8% |
| 2020 | -0.01x | $-2.70 Million | $-15.42 Million | $185.71 Million | ▲ +95.1% |
| 2019 | -0.29x | $-32.68 Million | $-35.21 Million | $111.20 Million | ▼ -174.0% |
| 2018 | -0.11x | $-24.83 Million | $-25.20 Million | $231.53 Million | ▼ -22.3% |
| 2017 | -0.09x | $-22.48 Million | $-24.10 Million | $256.42 Million | ▲ +34.8% |
| 2016 | -0.13x | $-34.03 Million | $-39.10 Million | $253.16 Million | ▼ -43.2% |
| 2015 | -0.09x | $-24.04 Million | $-34.70 Million | $256.16 Million | ▼ -58.6% |
| 2014 | -0.06x | $-15.22 Million | $-22.62 Million | $257.14 Million | ▼ -137.9% |
| 2013 | 0.16x | $3.10 Million | $-1.59 Million | $19.80 Million | ▲ +113.5% |
| 2012 | -1.15x | $-15.09 Million | $-17.48 Million | $13.07 Million | ▼ -63.2% |
| 2011 | -0.71x | $-15.87 Million | $-17.54 Million | $22.43 Million | ▼ -1418.3% |
| 2010 | -0.05x | $-9.97 Million | $-11.51 Million | $213.97 Million | ▲ +48.8% |
| 2009 | -0.09x | $-18.71 Million | $-19.51 Million | $205.77 Million | ▲ +37.6% |
| 2008 | -0.15x | $-27.81 Million | $-28.72 Million | $190.69 Million | ▼ -29.9% |
| 2007 | -0.11x | $-20.79 Million | $-21.76 Million | $185.11 Million | ▲ +17.3% |
| 2006 | -0.14x | $-19.37 Million | $-22.31 Million | $142.66 Million | — |